FRANKLIN LAKES, N.J., March 5, 2026 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has obtained CE Marking for the Revello™ Vascular Covered Stent, a next-generation endovascular solution for the treatment of atherosclerotic lesions in the common and external iliac arteries. This advancement arrives at a pivotal moment, as lower‑extremity peripheral artery disease (PAD), which iliac artery disease is a key component—drives a substantial disability burden across the EU’s aging population.1,2 The Revello™ Vascular Covered Stent is designed to combine the flexibility of a nitinol self-expanding stent with the radial resistive force tailored for the iliac arteries.
Category Archives: AZBio News
University of Arizona remembers former President Eugene G. Sander
Former University of Arizona President Eugene G. Sander passed away Feb. 22. He was 90.Continue reading
FDA Permits NuvOx Therapeutics to Initiate Phase II REBORN Trial of NanO2 in Recurrent High-Grade Glioma
Tucson, AZ –March 4, 2026, NuvOx Therapeutics, Inc. (“NuvOx”) today announced that the U.S. Food and Drug Administration (FDA) has authorized NuvOx to proceed with a new Phase II clinical trial evaluating NuvOx’s product candidate NanO2 (the active pharmaceutical ingredient of which is dodecafluoropentane) for the treatment of recurrent high-grade gliomas.Continue reading
Cinova Medical Acquires Elastomer Technologies, Inc.
Cinova Medical announced the acquisition of Elastomer Technologies, Inc. (ETI), a Southern California–based custom molder of liquid silicone rubber (LSR) and high-consistency gum rubbers serving the medical device and life sciences industries. ETI will continue operating from its current facility while Cinova Medical completes the expansion of a new Class 8 cleanroom dedicated to silicone molding. Upon completion, ETI’s manufacturing operations will be integrated into Cinova’s expanded production footprint. Headquartered in Phoenix, AZ, Cinova Medical is a vertically integrated contract manufacturer of precision-engineered, high-quality injection-molded and machined components, as well as complex Class II finished (sterile) medical devices.Continue reading
Senate Passes SBIR Reauthorization
On Tuesday, March 3, 2026, the Senate Unanimously Passed the Senate Bill 3971, the Small Business Innovation and Economic Security Act, that would extend the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs through Sept. 30, 2031. The measure now moves to the U.S. House of Representatives for final approval. Continue reading
Arizona Senate Recognizes 30 Years of Impact by the Velley Fever Center for Excellence
Dr. John Galgiani, professor of medicine and director of the University of Arizona Valley Fever Center for Excellence accepted an Arizona Legislative Proclamation on behalf of the team at the Valley Fever Center for Excellence.
Valley Fever is a dangerous and potentially fatal disease. More than half of all U.S. cases are reported in the state of Arizona.Continue reading
AZ House HHS Testimony Supporting the Arizona Health Innovation Trust Fund
HB 2727: appropriations; health innovation trust fund is sponsored by Representative Selina Bliss, Chairman of the Arizona House of Representatives Health and Human Services Committee (H-HHS) and co-chair of the Arizona Bioscience and Healthcare Caucus. House Bill 2727 was heard in H-HHS on February 2, 2026. The bill passed out of committee with a Do Pass recommendation on a vote of Continue reading
Tales from The Road – Terrence Stull, MD – Founder of BacVax
Listen in as Dr. Terry Stull shares his journey from academic medicine and clinical research leadership to biotech entrepreneurship.Continue reading
Rare Disease Day 2026 – AZBio Community Speaks Up for Patients
Each February 28th, the world recognizes the needs of patients living with rare diseases on Rare Disease Day. From meetings at our nation’s capitol to podcasts highlighting work being done here in Arizona, an upcoming events at the State Capitol, and at Voice of the Patient during AZ Tech Week that amplifies the voices of patients, our AZBio community is working to make a difference for patients.Continue reading
AZBio Member Spotlight – Reference Medicine
Based in Arizona, Reference Medicine is redefining how oncology research teams access one of the most critical resources in healthcare innovation: high-quality, clinically annotated human biospecimens. This Phoenix-based biotech company is focused on solving one of the most persistent bottlenecks in cancer research and diagnostics.Continue reading